OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer Journal Article


Authors: Tammela, J.; Uenaka, A.; Ono, T.; Noguchi, Y.; Jungbluth, A. A.; Mhawech-Fauceglia, P.; Qian, F.; Schneider, S.; Sharma, S.; Driscoll, D.; Lele, S.; Old, L. J.; Nakayama, E.; Odunsi, K.
Article Title: OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer
Abstract: OY-TES-1 is a novel target that belongs to the family of 'cancer/testis' (CT) antigens. Our goal was to examine the expression and immunogenicity of OY-TES-1 in epithelial ovarian cancer (EOC) to determine its potential as a target for vaccine therapy. OY-TES-1 expression was determined by one-step reverse transcriptase PCR on 100 EOC samples, 5 EOC cell lines, and a panel of normal tissues. Immunohistochemistry (IHC) was performed on the same panel of EOC tissues. Sera from a sub-group of patients were tested for OY-TES-1 antibody by ELISA. Thymus and leukocytes were weakly positive for OY-TES-1 while the remaining 5 normal tissues were negative. Expression of OY-TES-1 by either RT-PCR and/or IHC was demonstrable in 69/100 (69%) tumors. Humoral immunity to OY-TES-1 was demonstrated in 1/10 (10%) serum samples from patients whose tumors expressed the antigen. The median follow-up of the patient population was 34 months. There was no correlation between antigen expression and stage, grade, histology and survival. OY-TES-1 is expressed in 69% of patients with EOC, is absent from normal ovarian tissue, and a proportion of patients show evidence of a specific humoral immune response. These findings make OY-TES-1 an attractive target for antigen-specific immunotherapy in EOC.
Keywords: immunohistochemistry; immunogenicity; antibody; prognostic indicator; ovarian tumor antigen
Journal Title: International Journal of Oncology
Volume: 29
Issue: 4
ISSN: 1019-6439
Publisher: Spandidos Publications  
Date Published: 2006-10-01
Start Page: 903
End Page: 910
Language: English
PROVIDER: scopus
PUBMED: 16964386
DOI/URL:
Notes: --- - "Cited By (since 1996): 8" - "Export Date: 4 June 2012" - "CODEN: IJONE" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Achim Jungbluth
    454 Jungbluth
  2. Lloyd J Old
    593 Old